Journal article icon

Journal article

Usability of mepolizumab single-use prefilled autoinjector for patient self-administration

Abstract:
Objective: To evaluate usability of mepolizumab as a liquid drug product self-administered via a single-use prefilled autoinjector (AI) by patients with severe eosinophilic asthma (SEA), or their caregivers, in-clinic and at home.

Methods: This open-label, single-arm, Phase IIIa study (NCT03099096; GSK ID: 204959) included patients aged ≥12 years with SEA who were either receiving mepolizumab (100 mg subcutaneously [SC]) every 4 weeks (Q4W) for ≥12... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1080/02770903.2019.1630641

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Oxford college:
St Edmund Hall
Role:
Author
ORCID:
0000-0002-4288-5973
Publisher:
Taylor and Francis
Journal:
Journal of Asthma More from this journal
Volume:
57
Issue:
9
Pages:
987-998
Publication date:
2019-06-28
Acceptance date:
2019-06-07
DOI:
EISSN:
1532-4303
ISSN:
0277-0903
Pmid:
31251090
Language:
English
Keywords:
Pubs id:
pubs:1028524
UUID:
uuid:d0be99f5-8254-4e6a-851b-2b5d1f78fea1
Local pid:
pubs:1028524
Source identifiers:
1028524
Deposit date:
2019-08-01

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP